NiKang Therapeutics
NiKang Therapeutics is a clinical-stage biotechnology company headquartered at 200 Powder Mill Road, Building E500, Wilmington, Delaware, founded in 2017 to discover and develop innovative small molecule medicines that help patients fight cancer. The company works from deep insights into disease biology and molecular pathways and applies structure-based drug design to targets long considered difficult to drug, spanning both inhibitor and targeted-protein-degradation modalities. Its lead programme, NKT2152, is an orally bioavailable allosteric HIF2alpha inhibitor in Phase 1/2 for clear cell renal cell carcinoma, VHL disease and other solid tumours; NKT3964 is a first-in-class selective CDK2 degrader in Phase 1 for advanced or metastatic solid tumours; NKT5097 is a first-in-class dual CDK2/4 degrader, also in Phase 1; and a KRAS G12D small molecule programme sits in discovery and IND-enabling work. NiKang raised a $10 million Series A in December 2017, a $50 million Series B in September 2020 and a $200 million Series C in May 2021, and has partnered its chemistry with Erasca on SHP2 and with Pfizer, Hansoh and Roche on HIF2. NiKang Therapeutics runs no developer program and publishes no product API, developer portal, API reference or machine-readable specification of its own. The only machine-readable surface reachable without credentials is the WordPress REST content API behind www.nikangtx.com, which is catalogued here — 210 registered routes across 17 namespaces, of which the anonymously readable read-only content families are described in openapi/.
NiKang Therapeutics publishes 9 APIs on the APIs.io network, including Posts API, Pages API, Team API, and 6 more. Tagged areas include Company, Biotechnology, Pharmaceuticals, Oncology, and Precision Medicine.
NiKang Therapeutics’ developer surface includes product news, authentication, and 23 more developer resources.
Kin Score
APIs 9
Individual APIs this provider publishes, each with its own machine-readable definition.
NiKang Therapeutics Posts API
News archive — press releases, clinical data announcements and scientific presentations. Sixteen posts published at harvest time, all in the `news` category.
NiKang Therapeutics Pages API
Corporate pages — about us, science and pipeline, news, careers, jobs, privacy policy and terms of use. Nine pages published at harvest time.
NiKang Therapeutics Team API
The7 theme `dt_team` custom post type carrying NiKang's named people — ten published at harvest time, split by the dt_team_category taxonomy into Board (7) and Officers (2). The...
NiKang Therapeutics Media API
Media library — logos, leadership headshots, pipeline graphics and press assets. Sixty-seven attachments present at harvest time.
NiKang Therapeutics Taxonomy API
Categories, tags and team categories, plus the taxonomy registry. Three post categories are registered (`news` with 16 posts, `timeline` and `uncategorized` both empty); the pos...
NiKang Therapeutics Search API
Cross-content search across every published object — posts, pages, dt_team members and terms — in one call. Returned six matches for `cdk2` at harvest time.
NiKang Therapeutics Discovery API
Route, post-type, taxonomy and status discovery documents. The /wp-json index publishes the full 210-route table across 17 namespaces and is the machine-readable contract this w...
NiKang Therapeutics Comments API
Comment collection. Registered and anonymously reachable, but empty — no object on this deployment carries comments.
NiKang Therapeutics oEmbed API
oEmbed 1.0 provider endpoint for www.nikangtx.com URLs. Verified live and anonymous — returns provider_name "Nikang Therapeutics" for the site root.
Scroll for all 9
MCP Servers 1
Model Context Protocol servers that expose these APIs to AI agents.
NiKang Therapeutics MCP Server
MCP SERVERPricing Plans 1
Published pricing tiers and plan structures.
Rate Limits 1
Documented rate limits and quota policies.
Nikang Therapeutics Rate Limits
RATE LIMITSSecurity Posture 2
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Agent Surfaces 3
MCP servers, agent skills, and machine-readable catalogs
Design & Contract 5
Pagination, idempotency, versioning, errors, and events
Build 1
SDKs, sample code, and the tooling you integrate with
Access & Security 2
Authentication, authorization, and security posture
Operate 1
Status, limits, changes, and where to get help
Commercial 3
Pricing, plans, and the legal terms of use
Company 7
The organization behind the API
Scroll for all 7
Other 3
Properties that don't map to a standard resource type
Source (apis.yml)
Work with this as data
Every provider here is available over the APIs.io API and to AI agents over MCP.